Skip to content

Medical-device intelligence

DBI: Complement C4, Antigen, Antiserum, Control

FDA product code DBI: Complement C4, Antigen, Antiserum, Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DBI
FDA device name
Complement C4, Antigen, Antiserum, Control
Device class
2
Regulation number
866.5240
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

34 clearance records and 2 recall records in the covered releases, across 29 source company names and 1 product codes. Dated history runs from Nov 2, 1977 to Aug 27, 2020.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
DBI · Complement C4, Antigen, Antiserum, Control342

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

36 matching records
Device / recordCompany in FDA recordSourceSource date
C4 ANTIGEN ANTIBODY CONTROLK834605 · DBITechnicon Instruments Corp.510(k)Jan 24, 1984FDA decision date
RABBIT ANTISERUM TO HUMAN C4K831906 · DBIDako Corp.510(k)Jul 19, 1983FDA decision date
FIAX COMPLEMENT C4 TEST KITK830669 · DBIIntl. Diagnostic Technology510(k)Apr 8, 1983FDA decision date
IMMUNOGL. FRCT. OF RABBIT ANTISER.-C4K812490 · DBIDako Corp.510(k)Sep 23, 1981FDA decision date
SCRIPPSYSTEM C4 RID KITK810502 · DBIScripps-Miles, Inc.510(k)Apr 8, 1981FDA decision date
GOAT ANTI-HUMAN COMPLEMENT C4K802196 · DBIProtos Laboratories510(k)Oct 31, 1980FDA decision date
COMPLEMENT C4 NEPHELOMETRIC ASSAYK801361 · DBIJ.T. Baker Chemical Co.510(k)Jun 30, 1980FDA decision date
RADIAL IMMUNODIFFUSION KIT-COMP. 3K772073 · DBIGelman Instrument Co.510(k)Feb 3, 1978FDA decision date
COMPLEMENT C4 NEPHELOMETRIC ASSAYK772247 · DBIKallestad Laboratories, Inc.510(k)Dec 22, 1977FDA decision date
HUMAN C4 COMPLEMENT CONTROL SERUMK772004 · DBIG.D. Searle and Co.510(k)Nov 3, 1977FDA decision date
PLATES FOR HUMAN C4 COMPLEMENTK772002 · DBIG.D. Searle and Co.510(k)Nov 2, 1977FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗